Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Resource Support Plus · 1 trial · 3 indications
Energy intake is calculated from a one-day diet record in which the patient lists the identity and quantity of all foods and beverages consumed in the designated 24 hour time period at the end of each week (Baseline - Week 14).
| Arm | Type | Description |
|---|---|---|
| Multimodal Nutrition Therapy | EXPERIMENTAL | To assess a multimodal nutrition therapy (primary nutrition intervention+ adjuvant nutrition therapy) with features adapted for patients with cancers of the head and neck receiving chemo-radiotherapy treatment, to maintain oral dietary intake during treatment. The regimen consists of 2 medical foods, each taken on an unrestricted basis (as and when preferred by each patient). Resource® Support Plus, a nutritionally complete Medical Food specifically for the dietary management of oncology patients with (risk of) malnutrition. BOOST® Soothe, a Medical Food formulated as a clear oral nutritional supplement for cancer patients with sensory alterations or oral discomfort due to cancer treatments, in particular chemo- and/or radiotherapy. |
| Standard of Care | NO_INTERVENTION | In this setting patients rely on oral dietary intake. Ordinary, commercially available ingredients and food products are consumed. The standard of care includes weekly consultation with specialist oncology Registered Dietitian. |
| Name | Type | Description |
|---|---|---|
| Resource® Support Plus | OTHER | Nestlé Resource Support Plus® is a high energy- and protein-density Medical Food enriched with omega 3 polyunsaturated fatty acids. This is a nutritionally complete formula, in an easy to swallow, palatable, concentrated low volume, available in 2 flavours optimized for cancer patients undergoing chemotherapy and/or radiation in taste tests. It provides in a 125 mL serving: 250 kcal, 11.5 g protein and 0.95g of omega-3 fatty acid (eicosapentaenoic acid, EPA). |
Inclusion Criteria: 1. Patients must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up. 2. Male or female 3. ≥18 years of age 4. Histopathologically confirmed primary squamous cell carcinoma of the oral cavity and oro...
Resource Support Plus is an investigational nutritional supplement being studied for the treatment of malnourishment, nutritional deficiency, and undernutrition. It is currently in Phase 2 clinical development for these conditions.
Resource Support Plus is being developed by Avalon GloboCare Corp., a biopharmaceutical company traded under the ticker ALBT. The company is conducting a Phase 2 clinical trial to evaluate the supplement in patients with nutritional deficiencies.
Resource Support Plus is in Phase 2 clinical development. It is an investigational product and has not been approved by regulatory authorities. A Phase 2 trial is currently recruiting participants to assess its effects on malnourishment and nutritional deficiency.
Resource Support Plus is being studied in a Phase 2 clinical trial with the identifier NCT05379712, titled "Nutritional Supplementation in Head and Neck Cancers." The trial is recruiting 81 participants in Canada and is open to adults aged 18 years and older.
Yes, the Phase 2 clinical trial of Resource Support Plus is randomized and uses a no-treatment control group. The study is not double-blinded, and it includes biomarker selection as part of its design. The trial is actively recruiting participants.